Am I alone, or are others wondering that trials seem to be happening at a snails pace. I have followed and invested in RCE for over two years. No new antibiotics have been discovered for 30 years, and resistant strains to present antibiotics is rising relentlessly. Here we have a company with various products that could alleviate the problem of rising resistence and we have statements of their plans including: "expected firstsubject dosing later this year and will run for approximately 12 months" "expected to see first patient dosing in the early part of next year" "with first patient dosingexpected Q4 2022"
I would have hoped there was slightly more urgency in their trials
RCE Price at posting:
72.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)